Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study

Sorafenib is a multikinase inhibitor that has received increasing attention due to its high efficacy in hepatocellular carcinoma treatment. However, its poor pharmacokinetic properties (limited water solubility, rapid elimination, and metabolism) still represent major bottlenecks that need to be ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartos, Adrian, Iancu, Ioana, Ciobanu, Lidia, Onaciu, Anca, Moldovan, Cristian, Moldovan, Alin, Moldovan, Radu Cristian, Tigu, Adrian Bogdan, Stiufiuc, Gabriela Fabiola, Toma, Valentin, Iancu, Cornel, Al Hajjar, Nadim, Stiufiuc, Rares Ionut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414144/
https://www.ncbi.nlm.nih.gov/pubmed/36014698
http://dx.doi.org/10.3390/nano12162833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414144/
https://www.ncbi.nlm.nih.gov/pubmed/36014698
http://dx.doi.org/10.3390/nano12162833

Ejemplares similares